BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10204610)

  • 1. Phospholipid turnover in the inflamed intestinal mucosa: arachidonic acid-rich phosphatidyl/plasmenyl-ethanolamine in the mucosa in inflammatory bowel disease.
    Morita H; Nakanishi K; Dohi T; Yasugi E; Oshima M
    J Gastroenterol; 1999 Feb; 34(1):46-53. PubMed ID: 10204610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmenylethanolamine in human intestinal mucosa detected by an improved method for analysis of phospholipid.
    Nakanishi K; Yasugi E; Morita H; Dohi T; Oshima M
    Biochem Mol Biol Int; 1994 Jun; 33(3):457-62. PubMed ID: 7951064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
    Zhang Z; Zhao X; Lv C; Li C; Zhi F
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.
    Boldyreva LV; Morozova MV; Saydakova SS; Kozhevnikova EN
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients.
    Buffinton GD; Doe WF
    Free Radic Res; 1995 Feb; 22(2):131-43. PubMed ID: 7704184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression alterations in inflamed and unaffected colon mucosa from patients with mild inflammatory bowel disease.
    Xu L; Ma L; Lian J; Yang J; Chen S
    Mol Med Rep; 2016 Mar; 13(3):2729-35. PubMed ID: 26861951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Zhang W; Teng G; Wu T; Tian Y; Wang H
    Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease.
    Pacheco S; Hillier K; Smith C
    Clin Sci (Lond); 1987 Oct; 73(4):361-4. PubMed ID: 3665357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of IL-16 in inflammatory bowel disease.
    Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
    Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD99 refers to the activity of inflammatory bowel disease.
    Zhou G; Yang W; Yu L; Yu T; Liu Z
    Scand J Gastroenterol; 2017 Mar; 52(3):359-364. PubMed ID: 27866429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease.
    Vizoso FJ; González LO; Corte MD; Corte MG; Bongera M; Martínez A; Martín A; Andicoechea A; Gava RR
    Scand J Gastroenterol; 2006 Sep; 41(9):1050-5. PubMed ID: 16938718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease.
    Carvalho AT; Elia CC; de Souza HS; Elias PR; Pontes EL; Lukashok HP; de Freitas FC; Lapa e Silva JR
    J Clin Gastroenterol; 2003 Feb; 36(2):120-5. PubMed ID: 12544193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
    Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
    Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Plasmalogen Content Does Not Influence Arachidonic Acid Levels or Distribution in Macrophages: A Role for Cytosolic Phospholipase A
    Lebrero P; Astudillo AM; Rubio JM; Fernández-Caballero L; Kokotos G; Balboa MA; Balsinde J
    Cells; 2019 Jul; 8(8):. PubMed ID: 31370188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.